185 related articles for article (PubMed ID: 22522615)
1. Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes.
Sung JY; Park SB; Liu YT; Kwai N; Arnold R; Krishnan AV; Lin CS
Diabetes; 2012 Jun; 61(6):1592-8. PubMed ID: 22522615
[TBL] [Abstract][Full Text] [Related]
2. Uncovering sensory axonal dysfunction in asymptomatic type 2 diabetic neuropathy.
Sung JY; Tani J; Chang TS; Lin CS
PLoS One; 2017; 12(2):e0171223. PubMed ID: 28182728
[TBL] [Abstract][Full Text] [Related]
3. Sensory and motor axonal excitability testing in early diabetic neuropathy.
Kristensen AG; Gylfadottir S; Itani M; Kuwabara S; Krøigård T; Khan KS; Finnerup NB; Andersen H; Jensen TS; Sindrup S; Tankisi H
Clin Neurophysiol; 2021 Jul; 132(7):1407-1415. PubMed ID: 34030050
[TBL] [Abstract][Full Text] [Related]
4. Axonal dysfunction prior to neuropathy onset in type 1 diabetes.
Arnold R; Kwai N; Lin CS; Poynten AM; Kiernan MC; Krishnan AV
Diabetes Metab Res Rev; 2013 Jan; 29(1):53-9. PubMed ID: 23008000
[TBL] [Abstract][Full Text] [Related]
5. Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy.
Krishnan AV; Lin CS; Kiernan MC
Brain; 2008 May; 131(Pt 5):1209-16. PubMed ID: 18362098
[TBL] [Abstract][Full Text] [Related]
6. Correlation between markers of peripheral nerve function and structure in type 1 diabetes.
Borire AA; Issar T; Kwai NC; Visser LH; Simon NG; Poynten AM; Kiernan MC; Krishnan AV
Diabetes Metab Res Rev; 2018 Oct; 34(7):e3028. PubMed ID: 29858541
[TBL] [Abstract][Full Text] [Related]
7. Altered nerve excitability properties in established diabetic neuropathy.
Krishnan AV; Kiernan MC
Brain; 2005 May; 128(Pt 5):1178-87. PubMed ID: 15758031
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of axonal excitability are not generalized in early multifocal motor neuropathy.
Cappelen-Smith C; Kuwabara S; Lin CS; Burke D
Muscle Nerve; 2002 Dec; 26(6):769-76. PubMed ID: 12451600
[TBL] [Abstract][Full Text] [Related]
9. The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In Vivo.
Kwai NC; Nigole W; Poynten AM; Brown C; Krishnan AV
PLoS One; 2016; 11(4):e0153389. PubMed ID: 27078166
[TBL] [Abstract][Full Text] [Related]
10. Association of corneal nerve loss with markers of axonal ion channel dysfunction in type 1 diabetes.
Tummanapalli SS; Issar T; Kwai N; Poynten A; Krishnan AV; Willcox M; Markoulli M
Clin Neurophysiol; 2020 Jan; 131(1):145-154. PubMed ID: 31765978
[TBL] [Abstract][Full Text] [Related]
11. In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes.
Kwai NCG; Arnold R; Poynten AM; Howells J; Kiernan MC; Lin CS; Krishnan AV
Clin Neurophysiol; 2016 Feb; 127(2):1700-1706. PubMed ID: 26725257
[TBL] [Abstract][Full Text] [Related]
12. Progression of axonal excitability abnormalities with increasing clinical severity of diabetic peripheral neuropathy.
Dhanapalaratnam R; Issar T; Poynten AM; Milner KL; Kwai NCG; Krishnan AV
Clin Neurophysiol; 2024 Apr; 160():12-18. PubMed ID: 38367309
[TBL] [Abstract][Full Text] [Related]
13. Excitability of motor and sensory axons in multifocal motor neuropathy.
Kovalchuk MO; Franssen H; van den Berg LH; van Schelven LJ; Sleutjes BTHM
Clin Neurophysiol; 2020 Nov; 131(11):2641-2650. PubMed ID: 32947198
[TBL] [Abstract][Full Text] [Related]
14. Peripheral nerve excitability measures at different target levels: the effects of aging and diabetic neuropathy.
Shibuta Y; Nodera H; Mori A; Okita T; Kaji R
J Clin Neurophysiol; 2010 Oct; 27(5):350-7. PubMed ID: 20844439
[TBL] [Abstract][Full Text] [Related]
15. Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients.
Issar T; Arnold R; Kwai NCG; Walker S; Yan A; Borire AA; Poynten AM; Pussell BA; Endre ZH; Kiernan MC; Krishnan AV
Clin Neurophysiol; 2019 Nov; 130(11):2088-2095. PubMed ID: 31541986
[TBL] [Abstract][Full Text] [Related]
16. Nerve excitability changes in critical illness polyneuropathy.
Z'Graggen WJ; Lin CS; Howard RS; Beale RJ; Bostock H
Brain; 2006 Sep; 129(Pt 9):2461-70. PubMed ID: 16901913
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.
Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC
Brain; 2009 Oct; 132(Pt 10):2712-23. PubMed ID: 19745023
[TBL] [Abstract][Full Text] [Related]
18. Tibial nerve axonal excitability in type 1 diabetes mellitus.
Gencpinar P; Çelmeli G; Duman Ö; Haspolat Ş; Uysal H
Muscle Nerve; 2019 Jan; 59(1):76-81. PubMed ID: 30019351
[TBL] [Abstract][Full Text] [Related]
19. Evolution of peripheral nerve function in humans: novel insights from motor nerve excitability.
Farrar MA; Park SB; Lin CS; Kiernan MC
J Physiol; 2013 Jan; 591(1):273-86. PubMed ID: 23006483
[TBL] [Abstract][Full Text] [Related]
20. Dysfunction of axonal membrane conductances in adolescents and young adults with spinal muscular atrophy.
Farrar MA; Vucic S; Lin CS; Park SB; Johnston HM; du Sart D; Bostock H; Kiernan MC
Brain; 2011 Nov; 134(Pt 11):3185-97. PubMed ID: 21926101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
